Category Archives: Healthcare

Collplant Holdings (CLGN) Gets a Buy Rating from H.C. Wainwright

In a report released today, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on Collplant Holdings (CLGN – Research Report), with a price target of $13.00. The company’s shares closed last Tuesday at $10.23. According to TipRanks.com, Ramakanth is

Analysts Offer Insights on Healthcare Companies: Zogenix (NASDAQ: ZGNX) and Xencor (NASDAQ: XNCR)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Zogenix (ZGNX – Research Report) and Xencor (XNCR – Research Report) with bullish sentiments. Zogenix (ZGNX) Mizuho Securities analyst Difei Yang reiterated

The Deputy Chairman & Senior Independent Director of Oxford BioMedica (Other OTC: OXBDF) is Selling Shares

Today, the Deputy Chairman & Senior Independent Director of Oxford BioMedica (OXBDF – Research Report), Andrew John William Heath, sold shares of OXBDF for $385.4K. This is Heath’s first Sell trade following 16 Buy transactions. Following Andrew John William Heath’s

The Chief Financial Officer of Acerus Pharmaceuticals (Other OTC: ASPCF) is Buying Shares

Today, the Chief Financial Officer of Acerus Pharmaceuticals (ASPCF – Research Report), Robert Martin Motz, bought shares of ASPCF for $3,435. Following this transaction Robert Martin Motz’s holding in the company was increased by 52% to a total of $10.03K.

Metacrine (MTCR) Receives a Buy from Canaccord Genuity

In a report released yesterday, Edward Nash from Canaccord Genuity maintained a Buy rating on Metacrine (MTCR – Research Report), with a price target of $19.00. The company’s shares closed last Monday at $7.92, close to its 52-week low of

Analysts Offer Insights on Healthcare Companies: Metacrine (NASDAQ: MTCR), Nucana (NASDAQ: NCNA) and Alnylam Pharma (NASDAQ: ALNY)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Metacrine (MTCR – Research Report), Nucana (NCNA – Research Report) and Alnylam Pharma (ALNY – Research Report) with bullish sentiments. Nucana (NCNA)